Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
RMD Open|March 10, 2022
Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapyPeter C Taylor, Rieke Alten, Jose María Álvaro Gracia, et al.Arthritis Research & Therapy|May 16, 2022
Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trialThomas Dörner, Ronald F van Vollenhoven, Andrea Doria, et al.Cancer Genetics|October 14, 2017
Significantly mutated genes and regulatory pathways in SCLC-a meta-analysisVarsha Sundaresan, Victor T Lin, Faming Liang, et al.Rheumatology and Therapy|January 20, 2023
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical StudiesPeter C Taylor, Yun-Fei Chen, Janet Pope, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 10, 2016
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer PrognosisXin Luo, Xiao Zang, Lin Yang, et al.BMC Medical Genetics|April 5, 2011
BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibilityNing Zhang, Xiaoyan Li, Kai Tao, et al.Clinical and Translational Gastroenterology|March 7, 2023
Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 StudyBoyd Steere, Jochen Schmitz, Nick Powell, et al.Human Heredity|July 10, 2008
Inflammatory gene haplotype-interaction networks involved in coronary collateral formationJian Zhang, Jakub J Regieli, Maria Schipper, et al.Lancet (London, England)|February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)Eric F Morand, Edward M Vital, Michelle Petri, et al.Diabetes Care|January 25, 2017
Serum Trypsinogen Levels in Type 1 DiabetesXia Li, Martha Campbell-Thompson, Clive H Wasserfall, et al.Pageof 10